Pymepharco (Vietnam)

The subject engages in manufacturing, trading, importing and exporting pharmaceutical products, medical equipment, materials and related chemicals. Strong brands are Tatanol, Coldflu Forte, Menison, Liverton, Vivace… As investigated, the subject was officially delisted on 06 Dec 2021 because it is not eligible as a public company according to the announcement of the State Securities Commission based on Point a, Clause 1, Article 120 of Decree 155/2020/ND-CP dated on 31 Dec 2020.Stada Arzneimittel AG through Stada Service Holding B.V. acquired the subject, from 49% in 2017 to 99.73% in 2021 to establish a basis for the Stada Group's expansion in Vietnam, one of the most important growth markets in Asia. Stada Arzneimittel AG has 100% interest in the subject's parent company.Besides the subject, Stada Group engaged in operation of other companies in Vietnam such as Stellapharm J.V. Co., Ltd. Due to the 50-50 joint venture status, Stellapharm J.V. Co., Ltd (former name: Stada - VN Joint Venture Co., Ltd) started to suffer certain restrictions in growth strategy and the difference in strategic development of shareholders. Thus, Stada Group divested all capital contributions in Stellapharm J.V. Co., Ltd and established a new company - Stada Vietnam Limited Liability Company in 2020. The subject and this company have the same address and are members of Stada Group. These facts indicate that Stada Group has pursued the expansion strategy through M&A and joint venture deals in the Vietnamese market.Most prominently, the authorities in EU confirmed that Stada Group's plant in Tuy Hoa City, Vietnam, meets European GMP (Good Manufacturing Practice) standards. This means that in the future the Group will also be able to produce in Vietnam to serve EU markets. With initiatives such as photovoltaic cells in Vietnam, this helps to save around 2,500 tons of CO2 in 2022. Being as one of 20 production sites of the Group with constant innovatations, Stada Group aspires to advance its contribution to sustainable pharmaceutical supply, minimize supply bottlenecks and ensure security of supply in Vietnam and other markets in the world.